Dawson Buck

Provexis plc is engaged in developing and licensing Fruitflow®, a patented natural extract from tomatoes which has been shown in human trials to reduce the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can lead to heart attack and stroke.